New retrospective study results compare the two most largely prescribed antidiabetic medication classes in addition to metformin, to determine the impact on the incidence of CV events in patients with T2DM. Dipeptidyl-peptidase-4 inhibitors (DPP-4i) and sulphonylureas (sulfonylureas in the US) (SU) are two of the most prescribed medication to date …
Read More »Type 2 Diabetes: The Impact of Vision and Hearing Impairments on CV Risk Outcomes and Mortality
A comprehensive study reveals the importance of ophthalmologic and otologic care in patients with T2DM due to the association of increased risks for cardiovascular events in those with a decline in vision and hearing abilities. It is known that patients with type 2 diabetes mellitus (T2DM) have an increased risk …
Read More »Diabetes Technology in T1D Youth & Pediatrics Used for Glucose Control and Obesity
In the SWEET project experience, a large cohort of patients was started on either an insulin pump, glucose sensor, or both to compare the HbA1c levels and weight gain while on their new therapy. Many health complications can arise from diabetes, especially for adolescents and children with type 1 diabetes, …
Read More »Physical Activity: a Cheaper and Better Way to Save Lives in Patients with Diabetes
Effective preventive strategies are needed to reduce cardiovascular disease, the leading cause of mortality and morbidity globally.
Read More »GLP-1 vs. DPP-4 in Reducing Mortality for T2D Patients with ESRD
Glucagon-like peptide-1 (GLP-1) receptor agonist can reduce mortality and improve cardiovascular outcomes among patients with type 2 diabetes and end-stage kidney disease, compared to dipeptidyl peptidase -4 inhibitor use.
Read More »Higher Inflammatory Markers Can Predict Severe Cognitive Impairment for Patients with T2D
There is strong evidence that circulating markers of systemic inflammation can predict long-term cognitive decline among older people with type 2 diabetes.
Read More »Diabetes Technology in T1D Youth & Pediatrics Used for Glucose Control and Obesity
In the SWEET project experience, a large cohort of patients was started on either an insulin pump, glucose sensor, or both to compare the HbA1c levels and weight gain while on their new therapy.
Read More »Lipid Profiling Can Predict the Risk of Diabetes and CVD Years Before Onset
The analysis of lipid profiling in the prediction of risk of developing type 2 diabetes and cardiovascular diseases can aid in recommending lifestyle changes and diet before the development of the diseases.
Read More »Can Caffeine be the Key to Fighting CVD?
Studies have found that average levels of moderate caffeine intake are related to lower cardiovascular risk.
Read More »Can a Calorie-Restricted Diet Improve Long-Term Progressive Kidney Function Decline?
Studies have found that there may be a benefit in implementing a calorie-restricted diet in patients with type 2 diabetes to improve glomerular hyperfiltration.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.